Jon is a deeply experienced pharmaceutical and biotech executive. Jon graduated with a Wharton MBA in finance and joined Eli Lilly & Company. He had ascending roles in finance, sales and marketing and then worked in Corporate Business Development where he did 40 deals very much like Stingray on the buy side for Lilly. Leaving as a SVP of Bus Dev, he then has started 3 biotechs as Cofounder and CEO, all of which are successful.

Sunil is a deeply experienced research clinical oncologist. he has a strong interest in translational therapeutics, has done over 150 phase 1-2 cancer clinical trials as primary investigator for virtually all of the cancer pharmas and biotechs. He is deputy director and chief physician at Translational Genomics Research Institute in Phoenix. He and Jon have built 3 cancer companies together.

Monil is a very experienced clinical trialist having been Chief Development Officer of WindMIl Therapeutics, Chief Operating Officer of Brooklyn ImmunoTherapeutics, WW Medical Lead in Immuno-Oncology at BMS, VP, Clinical Development and Operations at Ventrus Biosciences and Senior Director, Clinical Strategic Planning at Celgene

Mohan has a decade long research career in the discovery and development of small molecule inhibitors for dysregulated proteins in oncology. He specializes in using computational drug design and synthetic medicinal chemistry to design better molecules with suitable physiochemical properties required for drug delivery and efficacy. He also have developed extensive skills in all aspects of drug discovery and development.